pemetrexed,cisplatin,gemcitabine,pembrolizumab,Toripalimab,nivolumab,ipilimumab,Atezolizumab,Vinorelbine,Docetaxel,Carboplatin,Paclitaxel
merck,Coherus,Junshi Biosciences,roche,BMS
['biomarker', 'kn671', 'nsclc', 'sclc', 'lcsm,(-blcsm)']
#asco23 superb discussion of kn671 by where he highlights pro s and con s of the major questions from this study: - rationale or adj io based on pcr
- use of neoadj chemoio in oncogene-addicted nsclc
- proposed biomarker strategy #lcsm 
Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University